FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008446636> ?p ?o ?g. }

• W2008446636 endingPage "131" @default.
• W2008446636 startingPage "125" @default.
• W2008446636 abstract "A growing body of evidence indicates the prominent actions of melatonin on the opioidergic system. Nevertheless, effect of melatonin on rewarding properties of morphine is still obscure. In particular, effect of melatonin on the expression of morphine reward is unknown. We evaluated the effect of exogenous administration of melatonin on the expression of morphine reward in mice using a conditioned place preference (CPP) paradigm. The conditioned place preference was induced by morphine (s.c., 3 mg/kg, once each day for 5 consecutive days) in mice. Our data showed that the intraperitoneal (i.p.) administration of melatonin (12.5-50 mg/kg) reversed the expression of morphine-induced conditioned place preference in a dose-dependent manner. Furthermore, the intracerebroventricular (i.c.v.) administration of melatonin (0.125-0.5 mg/kg) also resulted in dose-dependent reversal effect on the expression of morphine-induced conditioned place preference. We further investigated which of melatonin receptor subtypes within the central nervous system was mediating this reversal action in mice using luzindole (2-benzyl-N-acetyltryptamine, a non-selective antagonist for melatonin MT1 and MT2 receptors) and K185 (N-butanoyl-2-(5,6,7-trihydro-11-methoxybenzo[3,4]cyclohept[2,1-alpha]indol-13-yl)ethanamine, a selective antagonist for melatonin MT2 receptor). It was shown that the i.c.v. administration of either K185 (5, 20 microg) or luzindole (6.25, 12.5 microg) significantly antagonized the reversal effect of melatonin (50 mg/kg, i.p) on the expression of morphine-induced conditioned place preference, while the i.c.v. administration of 20 microg of K185 or 12.5 microg of luzindole by itself did not alter the expression of morphine-induced conditioned place preference. These results suggest that melatonin reverses the expression of morphine-induced rewarding effect, and this action is mediated by the activation of melatonin MT2 receptor subtype within the central nervous system." @default.
• W2008446636 created "2016-06-24" @default.
• W2008446636 creator A5020269223 @default.
• W2008446636 creator A5041322575 @default.
• W2008446636 creator A5045422751 @default.
• W2008446636 creator A5064620149 @default.
• W2008446636 creator A5076974102 @default.
• W2008446636 date "2008-10-01" @default.
• W2008446636 modified "2023-10-14" @default.
• W2008446636 title "Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice" @default.
• W2008446636 cites W1504636011 @default.
• W2008446636 cites W1913760354 @default.
• W2008446636 cites W1935218545 @default.
• W2008446636 cites W1936195323 @default.
• W2008446636 cites W1964759272 @default.
• W2008446636 cites W1965728794 @default.
• W2008446636 cites W1970936174 @default.
• W2008446636 cites W1974400595 @default.
• W2008446636 cites W1974642119 @default.
• W2008446636 cites W1995409766 @default.
• W2008446636 cites W2006461362 @default.
• W2008446636 cites W2008228907 @default.
• W2008446636 cites W2013940388 @default.
• W2008446636 cites W2024125893 @default.
• W2008446636 cites W2025517512 @default.
• W2008446636 cites W2030835553 @default.
• W2008446636 cites W2031038825 @default.
• W2008446636 cites W2044305686 @default.
• W2008446636 cites W2049985521 @default.
• W2008446636 cites W2055873275 @default.
• W2008446636 cites W2056130856 @default.
• W2008446636 cites W2060226539 @default.
• W2008446636 cites W2063977634 @default.
• W2008446636 cites W2065340163 @default.
• W2008446636 cites W2067055276 @default.
• W2008446636 cites W2070530252 @default.
• W2008446636 cites W2075058479 @default.
• W2008446636 cites W2086909446 @default.
• W2008446636 cites W2123329342 @default.
• W2008446636 cites W2130711954 @default.
• W2008446636 cites W2153702661 @default.
• W2008446636 cites W2169938627 @default.
• W2008446636 doi "https://doi.org/10.1016/j.ejphar.2008.07.049" @default.
• W2008446636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18706407" @default.
• W2008446636 hasPublicationYear "2008" @default.
• W2008446636 type Work @default.
• W2008446636 sameAs 2008446636 @default.
• W2008446636 citedByCount "17" @default.
• W2008446636 countsByYear W20084466362013 @default.
• W2008446636 countsByYear W20084466362015 @default.
• W2008446636 countsByYear W20084466362016 @default.
• W2008446636 countsByYear W20084466362018 @default.
• W2008446636 countsByYear W20084466362020 @default.
• W2008446636 countsByYear W20084466362021 @default.
• W2008446636 countsByYear W20084466362022 @default.
• W2008446636 countsByYear W20084466362023 @default.
• W2008446636 crossrefType "journal-article" @default.
• W2008446636 hasAuthorship W2008446636A5020269223 @default.
• W2008446636 hasAuthorship W2008446636A5041322575 @default.
• W2008446636 hasAuthorship W2008446636A5045422751 @default.
• W2008446636 hasAuthorship W2008446636A5064620149 @default.
• W2008446636 hasAuthorship W2008446636A5076974102 @default.
• W2008446636 hasConcept C126322002 @default.
• W2008446636 hasConcept C134018914 @default.
• W2008446636 hasConcept C170493617 @default.
• W2008446636 hasConcept C185592680 @default.
• W2008446636 hasConcept C2776885963 @default.
• W2008446636 hasConcept C2777389121 @default.
• W2008446636 hasConcept C2778122271 @default.
• W2008446636 hasConcept C2778182776 @default.
• W2008446636 hasConcept C2778750930 @default.
• W2008446636 hasConcept C2779004600 @default.
• W2008446636 hasConcept C2781269140 @default.
• W2008446636 hasConcept C2781416619 @default.
• W2008446636 hasConcept C35124327 @default.
• W2008446636 hasConcept C71924100 @default.
• W2008446636 hasConcept C98274493 @default.
• W2008446636 hasConceptScore W2008446636C126322002 @default.
• W2008446636 hasConceptScore W2008446636C134018914 @default.
• W2008446636 hasConceptScore W2008446636C170493617 @default.
• W2008446636 hasConceptScore W2008446636C185592680 @default.
• W2008446636 hasConceptScore W2008446636C2776885963 @default.
• W2008446636 hasConceptScore W2008446636C2777389121 @default.
• W2008446636 hasConceptScore W2008446636C2778122271 @default.
• W2008446636 hasConceptScore W2008446636C2778182776 @default.
• W2008446636 hasConceptScore W2008446636C2778750930 @default.
• W2008446636 hasConceptScore W2008446636C2779004600 @default.
• W2008446636 hasConceptScore W2008446636C2781269140 @default.
• W2008446636 hasConceptScore W2008446636C2781416619 @default.
• W2008446636 hasConceptScore W2008446636C35124327 @default.
• W2008446636 hasConceptScore W2008446636C71924100 @default.
• W2008446636 hasConceptScore W2008446636C98274493 @default.
• W2008446636 hasIssue "1-3" @default.
• W2008446636 hasLocation W20084466361 @default.
• W2008446636 hasLocation W20084466362 @default.
• W2008446636 hasOpenAccess W2008446636 @default.
• W2008446636 hasPrimaryLocation W20084466361 @default.
• W2008446636 hasRelatedWork W1971852532 @default.

• next